A. V. Ulasov

1.1k total citations · 1 hit paper
31 papers, 837 citations indexed

About

A. V. Ulasov is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, A. V. Ulasov has authored 31 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Infectious Diseases. Recurrent topics in A. V. Ulasov's work include RNA Interference and Gene Delivery (18 papers), Advanced biosensing and bioanalysis techniques (16 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). A. V. Ulasov is often cited by papers focused on RNA Interference and Gene Delivery (18 papers), Advanced biosensing and bioanalysis techniques (16 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). A. V. Ulasov collaborates with scholars based in Russia, Tajikistan and United States. A. V. Ulasov's co-authors include Alexander S. Sobolev, Andrey A. Rosenkranz, Georgii P. Georgiev, Tatiana A. Slastnikova, Yuri V. Khramtsov, E. D. Sverdlov, R. I. Yakubovskaya, Mikhail Durymanov, Е. Д. Свердлов and Н. Б. Морозова and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and Life Sciences.

In The Last Decade

A. V. Ulasov

27 papers receiving 828 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nrf2/Keap1/ARE signaling: Towards specific regulation

2021 350 citations A. V. Ulasov, Andrey A. Rosenkranz et al. profile →

Peers

A. V. Ulasov

RNMI

ONCOL

GENET

BIOMA

Christina L. Grek United States

Su‐Jae Lee South Korea

Xiaoyong Dai China

Xiangbin Zeng United States

Wei Xiao China

Yeoun‐Hee Kim South Korea

Mahin Khatami United States

Zhenzhen Zhang China

Muhammad Anas Kamleh United Kingdom

Ji Liu China

Christina L. Grek United States

A. V. Ulasov

1.1k ×1.8

42 ×0.3

RNMI

101 ×1.1

ONCOL

65 ×0.8

GENET

59 ×0.8

BIOMA

Citations per year, relative to A. V. Ulasov A. V. Ulasov (= 1×) peers Christina L. Grek

Countries citing papers authored by A. V. Ulasov

Since Specialization

Citations

This map shows the geographic impact of A. V. Ulasov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. V. Ulasov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. V. Ulasov more than expected).

Fields of papers citing papers by A. V. Ulasov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. V. Ulasov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. V. Ulasov. The network helps show where A. V. Ulasov may publish in the future.

Co-authorship network of co-authors of A. V. Ulasov

This figure shows the co-authorship network connecting the top 25 collaborators of A. V. Ulasov. A scholar is included among the top collaborators of A. V. Ulasov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. V. Ulasov. A. V. Ulasov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khramtsov, Yuri V., A. V. Ulasov, Andrey A. Rosenkranz, et al.. (2024). Modular Nanotransporters Deliver Anti-Keap1 Monobody into Mouse Hepatocytes, Thereby Inhibiting Production of Reactive Oxygen Species. Pharmaceutics. 16(10). 1345–1345. 1 indexed citations

Ulasov, A. V., et al.. (2024). Optimization of a Modular Nanotransporter Design for Targeted Intracellular Delivery of Photosensitizer. Pharmaceutics. 16(8). 1083–1083.

Khramtsov, Yuri V., A. V. Ulasov, Andrey A. Rosenkranz, et al.. (2023). An Approach to Evaluate the Effective Cytoplasmic Concentration of Bioactive Agents Interacting with a Selected Intracellular Target Protein. Pharmaceutics. 15(2). 324–324. 6 indexed citations

Khramtsov, Yuri V., et al.. (2023). Modular Nanotransporters Capable of Causing Intracellular Degradation of the N-Protein of the SARS-CoV-2 Virus in A549 Cells with Temporary Expression of This Protein Fused with a Fluorescent Protein mRuby3. Doklady Biochemistry and Biophysics. 513(S1). S60–S62.

Khramtsov, Yuri V., A. V. Ulasov, Tatiana A. Slastnikova, et al.. (2023). Modular Nanotransporters Delivering Biologically Active Molecules to the Surface of Mitochondria. Pharmaceutics. 15(12). 2687–2687. 3 indexed citations

Khramtsov, Yuri V., et al.. (2023). Modular Nanotransporters Capable of Binding to SARS-CoV-2 Virus Nucleocapsid Protein in Target Cells. Doklady Biochemistry and Biophysics. 510(1). 87–90. 3 indexed citations

Ulasov, A. V., et al.. (2023). Intracellular Delivery of an Antibody-Like Molecule Capable of Inhibiting c-Myc. Doklady Biochemistry and Biophysics. 509(1). 70–72. 3 indexed citations

Khramtsov, Yuri V., et al.. (2022). Delivery of Antibody-Like Molecules, Monobodies, Capable of Binding with SARS-CoV-2 Virus Nucleocapsid Protein, into Target Cells. Doklady Biochemistry and Biophysics. 506(1). 220–222. 5 indexed citations

Ulasov, A. V., Tatiana A. Slastnikova, Andrey A. Rosenkranz, et al.. (2020). Targeted Delivery of 111In Into the Nuclei of EGFR Overexpressing Cells via Modular Nanotransporters With Anti-EGFR Affibody. Frontiers in Pharmacology. 11. 176–176. 17 indexed citations

10.

Ulasov, A. V., Andrey A. Rosenkranz, Tatiana A. Slastnikova, et al.. (2020). New Recombinant Carriers Binding Specifically to the Epidermal Growth Factor Receptor. Doklady Biochemistry and Biophysics. 490(1). 22–24. 1 indexed citations

11.

Rosenkranz, Andrey A., Tatiana A. Slastnikova, Т. А. Кармакова, et al.. (2018). Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression. Frontiers in Pharmacology. 9. 1331–1331. 36 indexed citations

12.

Khramtsov, Yuri V., A. V. Ulasov, Andrey A. Rosenkranz, G. P. Georgiev, & Alexander S. Sobolev. (2018). Study of Biodistribution of the Modular Nanotransporters after Systemic Administration in Murine Cloudman S91 Melanoma Model. Doklady Biochemistry and Biophysics. 478(1). 55–57. 5 indexed citations

13.

Rosenkranz, Andrey A., et al.. (2018). Modular Nanotransporter with P21 Fragment Inhibits DNA Repair after Bleomycin Treatment. Doklady Biochemistry and Biophysics. 479(1). 95–97. 3 indexed citations

14.

Slastnikova, Tatiana A., Andrey A. Rosenkranz, Н. Б. Морозова, et al.. (2017). Preparation, cytotoxicity, and in vivo antitumor efficacy of <sup>111</sup>In-labeled modular nanotransporters. International Journal of Nanomedicine. Volume 12. 395–410. 20 indexed citations

15.

Khramtsov, Yuri V., et al.. (2017). Characterization of new modular nanotransporters with albumin-binding domain. Doklady Biochemistry and Biophysics. 472(1). 81–83. 6 indexed citations

16.

Snezhkov, E. V., И. П. Чернов, V. K. Potapov, et al.. (2015). Therapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer. Journal of Translational Medicine. 13(1). 78–78. 29 indexed citations

17.

Rosenkranz, Andrey A., A. V. Ulasov, Tatiana A. Slastnikova, Yuri V. Khramtsov, & Alexander S. Sobolev. (2014). Use of intracellular transport processes for targeted drug delivery into a specified cellular compartment. Biochemistry (Moscow). 79(9). 928–946. 17 indexed citations

18.

Durymanov, Mikhail, A. V. Ulasov, Yuri V. Khramtsov, et al.. (2012). Subcellular trafficking and transfection efficacy of polyethylenimine–polyethylene glycol polyplex nanoparticles with a ligand to melanocortin receptor-1. Journal of Controlled Release. 163(2). 211–219. 32 indexed citations

19.

Ulasov, A. V., Yuri V. Khramtsov, Mikhail Durymanov, et al.. (2011). Investigation of transport and unpacking mechanisms of polyplexes for transfection efficacy on different cell lines. Doklady Biochemistry and Biophysics. 437(1). 77–79. 7 indexed citations

20.

Ulasov, A. V., et al.. (2010). Properties of PEI-based Polyplex Nanoparticles That Correlate With Their Transfection Efficacy. Molecular Therapy. 19(1). 103–112. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact